Pelikan Technologies Funding Round

12/6/2007

Debt
Venture Equity

$89,000,000

Series F

Pelikan intends to use a portion of the proceeds from this financing to support the company's near-term commercialization of the FDA-approved Pelikan Sun(TM) electronic lancing device. After a successful launch of the Pelikan Sun in Australia in October, and in Europe in November, the company will launch the device in the U.S. during the first quarter of 2008. In addition, the company will use the proceeds to complete development of its next-generation, fully-integrated blood glucose system and support that product's anticipated 2008 launch, as well as to fund research and development for future Pelikan products.

Out of Business

Medical Devices & Instruments

1072 East Meadow Circle
Palo Alto, CA 94303
USA

Pelikan Technologies is dedicated to the development of innovative hand-held diagnostic and monitoring devices capable of significantly improving the screening and management of a variety of medical conditions.